Evidence map›Paper›PMID 31770404›Full record

ArticlePloS one2019

Differential phosphorylation determines the repressor and activator potencies of GLI1 proteins and their efficiency in modulating the HPV life cycle.

Alla Piirsoo, Anne Pink, Lagle Kasak, Martin Kala, Sergo Kasvandik, Mart Ustav, Marko Piirsoo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Downregulation of Sonic hedgehog signaling induces G2-arrest in genital warts.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
  5. When Viruses Cross Developmental Pathways.Frontiers in cell and developmental biology · 2021
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alla PiirsooInstitute of Technology, University of Tartu, Tartu, Estonia.
Anne PinkDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.
Lagle KasakDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.
Martin KalaInstitute of Technology, University of Tartu, Tartu, Estonia.
Sergo KasvandikInstitute of Technology, University of Tartu, Tartu, Estonia.
Mart UstavInstitute of Technology, University of Tartu, Tartu, Estonia.
Marko PiirsooInstitute of Technology, University of Tartu, Tartu, Estonia.ORCID 0000-0002-9447-1350
University of Tartu · EETallinn University of Technology · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Sonic Hedgehog (Shh) signalling pathway plays multiple roles during embryonic development and under pathological conditions. Although the core components of the Shh pathway are conserved, the regulation of signal transduction varies significantly among species and cell types. Protein kinases Ulk3 and Pka are involved in the Shh pathway as modulators of the activities of Gli transcription factors, which are the nuclear mediators of the signal. Here, we investigate the regulation and activities of two GLI1 isoforms, full-length GLI1 (GLI1FL) and GLI1ΔN. The latter protein lacks the first 128 amino acids including the conserved phosphorylation cluster and the binding motif for SUFU, the key regulator of GLI activity. Both GLI1 isoforms are co-expressed in all human cell lines analysed and possess similar DNA binding activity. ULK3 potentiates the transcriptional activity of both GLI1 proteins, whereas PKA inhibits the activity of GLI1ΔN, but not GLI1FL. In addition to its well-established role as a transcriptional activator, GLI1FL acts as a repressor by inhibiting transcription from the early promoters of human papillomavirus type 18 (HPV18). Additionally, compared to GLI1ΔN, GLI1FL is a more potent suppressor of replication of several HPV types. Altogether, our data show that the N-terminal part of GLI1FL is crucial for the realization of its full potential as a transcriptional regulator.

Indexed as

Amino Acid SequenceBinding SitesCell LineCyclic AMP-Dependent Protein KinasesDNAHumansOncogene Proteins, ViralPapillomaviridaePhosphorylationPromoter Regions, GeneticProtein BindingProtein IsoformsRepressor ProteinsSequence AlignmentTranscriptional ActivationVirus ReplicationCyclic AMP-Dependent Protein KinasesDNAGLI1 protein, humanOncogene Proteins, ViralProtein IsoformsRepressor ProteinsSUFU protein, humanZinc Finger Protein GLI1

Identifiers

PMID31770404
PMCPMC6879148
OpenAlexW2990058491

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.